Incyte
INCY
#1125
Rank
โ‚น1.773 T
Marketcap
โ‚น9,035
Share price
-1.02%
Change (1 day)
42.95%
Change (1 year)

Operating Margin for Incyte (INCY)

Operating Margin as of December 2025 (TTM): 32.99%

According to Incyte's latest financial reports and stock price the company's current Operating Margin is 32.99%. At the end of 2024 the company had an Operating Margin of 7.52%.

Operating Margin history for Incyte from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
20247.52%-66.79%
202322.64%44.53%
202215.67%-18.27%
202119.17%-322.18%
2020-8.63%-138.11%
201922.64%264.42%
20186.21%-131.25%
2017-19.88%-250.4%
201613.22%87.41%
20157.05%-2198.53%
2014-0.34%-97.3%
2013-12.45%-2034.52%
20120.64%-100.43%
2011-151.10%-2336.51%
20106.76%-100.45%
2009-1,508.56%-62.88%
2008-4,064.53%1541.45%
2007-247.62%-10.95%
2006-278.06%-78.35%
2005-1,284.53%22.07%
2004-1,052.26%275.65%
2003-280.12%101.65%
2002-138.92%370.78%
2001-29.51%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Amgen
AMGN
22.91%-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
1.50%-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
37.87% 14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.60%-61.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-226.73%-787.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-13.94%-142.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12%-11.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-30.78%-193.30%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-172.37%-622.49%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.